Garth Smith
Directeur/Membre du Conseil chez MicroGEM International Plc
Profil
Garth Smith has been the Director at MicroGEM International Plc since 2015.
Postes actifs de Garth Smith
| Sociétés | Poste | Début |
|---|---|---|
MicroGEM International Plc
 MicroGEM International Plc Medical SpecialtiesHealth Technology MicroGEM International Plc specializes in DNA and RNA extraction using a single-tube approach that produces high-quality extracts with no loss of genetic material, reduced plastic waste, and no harsh chemicals. MicroGEM is based in Southampton, UK, and has subsidiaries in the United States. The British company's prepGEM kit is formulated to efficiently extract DNA from various blood sources, while forensicGEM allows for effortless DNA extraction from saliva samples, virtually eliminating sample contamination issues. MicroGEM's resources and collaborations provide faster, superior results for DNA extraction across a wide variety of sample types. The company's RNAGEM V kit uses a novel thermophilic proteinase and buffer system to extract nucleic acids from viruses in less than 15 minutes without the need for purification. The CEO of the company is Jeff Chapman. | Directeur/Membre du Conseil | 21/10/2015 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
MicroGEM International Plc
MicroGEM International Plc Medical SpecialtiesHealth Technology MicroGEM International Plc specializes in DNA and RNA extraction using a single-tube approach that produces high-quality extracts with no loss of genetic material, reduced plastic waste, and no harsh chemicals. MicroGEM is based in Southampton, UK, and has subsidiaries in the United States. The British company's prepGEM kit is formulated to efficiently extract DNA from various blood sources, while forensicGEM allows for effortless DNA extraction from saliva samples, virtually eliminating sample contamination issues. MicroGEM's resources and collaborations provide faster, superior results for DNA extraction across a wide variety of sample types. The company's RNAGEM V kit uses a novel thermophilic proteinase and buffer system to extract nucleic acids from viruses in less than 15 minutes without the need for purification. The CEO of the company is Jeff Chapman. | Health Technology |
